Overview
Osteoporosis: the silent risk you can now see
Osteoporosis affects millions, often going undiagnosed until a fracture occurs. More than 70% of patients with fragility fractures are never tested or treated for osteoporosis1.
Traditional care pathways are failing, leaving millions at risk and driving up healthcare costs.
TBS Reveal* is designed to help close this gap by detecting fragility earlier, directly from routine X-rays.


Capture patients with high bone fragility earlier
TBS Reveal* provides instant bone quality assessments from many commonly performed X-ray exams.
The only opportunistic AI X-ray software that assesses combined bone mass (BMD) and bone microarchitecture (TBS).
Seamlessly integrated into PACS, TBS Reveal* delivers results effortlessly within daily workflows.
Turn routine X-rays into early insights with TBS Reveal*
PROACTIVE DETECTION
Automatic AI bone fragility detection. Seamlessly integrated into PACS.
COMBINED ASSESSMENTS
Assessing combined bone mass (BMD) and bone microarchitecture (TBS).
LARGER POPULATION
Support inclusive care by extending detection of patients at risk of bone fragility from 20 years old.
SMART FLAG
Sustainable AI model to identify high-risk cases with accurate detection and efficient resource use.
Bone Fragility Assessment report for clinicians
TBS Reveal* enables the automatic generation of reports powered by AI-driven analysis, supporting timely and informed decisions.
Instant report combining:
- Trabecular Bone Score (TBS): a measure of bone quality microarchitecture.
- Bone Fragility Index: combines TBS and bone mass (BMD) into one indicator.
- AI Heatmap: visual overlay highlighting areas of bone fragility.
- DICOM: secondary capture and structured report options.
The report is seamlessly integrated into PACS for immediate access.

See more. Detect earlier. Treat smarter
See more in every X-ray

All patients with routine X-rays
Identify patients with high bone fragility

Combined bone microarchitecture and bone mass
Accelerate diagnosis

Based on the TBS Reveal report, clinicians can accelerate osteoporosis detection by recommending a
DXA test & TBS Osteo assessment for early diagnosis
Powered by clinically robust insights
- Over 18,500 paired DXA and X-ray images
A broad dataset powering opportunistic AI X-ray analysis, providing the most robust foundation for fragility risk modeling. - High-specificity design
Fewer patients flagged, but with higher accuracy — ensuring sustainable referrals. - Multi-ethnicity validation
Proven across diverse cohorts and generalizable across imaging systems.
| AUC | Accuracy | Specificity |
|---|---|---|
| 85% | 90% | 95% |
Resources

TBS Reveal* brochure
Explore how TBS Reveal* helps clinicians detect patients with high bone fragility earlier.

TBS Reveal* report
Explore the report that supports timely, confident assessment of bone fragility.
Request a demo
Contact us to experience how TBS Reveal* uncovers bone fragility risk in routine X-rays.
* TBS Reveal is currently pending FDA clearance
1. Compstson 2020; Bluic et al.; 2021
2. Gatineau et al., under review 2025
